Kelsey Coyle, MD
Allergy & Immunology · Lexington, KYNPI 1083077002
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,271, more than ten times the $25 reported in 2020. That places this record below the midpoint for allergy & immunology clinicians in KY, where the typical reported total is $7,092.
Across 144 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$627
- Sanofi$555
- GSK$285
- Novartis$235
- Amgen$215
- CSL Behring$179
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,123100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $627 |
| Sanofi | 22 | $555 |
| GSK | 18 | $285 |
| Novartis | 11 | $235 |
| Amgen | 7 | $215 |
| CSL Behring | 10 | $179 |
| Pfizer | 7 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $132 |
| Kaleo, Inc. | 6 | $131 |
| Optinose US, Inc. | 7 | $110 |
| Genentech USA, Inc. | 5 | $101 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Blueprint Medicines Corporation | 2 | $42 |
| Grifols USA, LLC | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Hikma Pharmaceuticals USA | 2 | $33 |
| Boehringer Ingelheim | 2 | $32 |
| Pharming Healthcare, Inc. | 1 | $29 |
| Alk-abello, Inc | 1 | $24 |
| Cycle Pharmaceuticals Inc | 1 | $24 |
| LEO Pharma Inc. | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$121
How this compares
$3,123 in reported general payments places this provider in the 35th percentile of 66 allergy & immunology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CuvitruImmun Glob G(Igg)/Gly/Iga Ov50 | 52 | $290,484 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $42,418 |
| Epinephrine | 35 | $7,582 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $7,170 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $4,938 |
| Qvar RedihalerBeclomethasone Dipropionate | 11 | $2,262 |
| Azelastine Hcl | 84 | $1,954 |
| Fluticasone Propionate | 53 | $784 |
| Ipratropium Bromide | 39 | $764 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $692 |
| Montelukast Sodium | 62 | $336 |
| Levocetirizine Dihydrochloride | 33 | $167 |
| Famotidine | 11 | $136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Cuvitru | $132 | $290,48452 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $285 | $49,58861 claims |
| Hikma Pharmaceuticals USAEpinephrine | $33 | $7,58235 claims |
| AstraZenecaSymbicort | $627 | $4,93816 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $46 | $2,26211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 66 allergy & immunology providers in Kentucky.
Other allergy & immunology in Lexington
- Rajiv AroraLexington$144K
- Priya WarrierLexington$93K
- William GreisnerLexington$39K
- Tracie OverbeckLexington$19K
- Shuya WuLexington$10K
- Shaunah RitterLexington$7K
- Alexander PattersonLexington$6K
- Amy MashburnLexington$2K
- Leslie BranchLexington$1K
- John ThompsonLexington$258
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.